Briggs v. Briggs

Briggs v. Briggs
Case name	Briggs v. Briggs
Court	Supreme Court of the United Kingdom
Date decided	2016
Citations	[2016] UKSC 32
Judges	Lord Neuberger, Lady Hale, Lord Kerr, Lord Hughes, Lord Mance

Briggs v. Briggs was a 2016 decision of the Supreme Court of the United Kingdom addressing the legal status of patients in prolonged disorders of consciousness and the application of the Mental Capacity Act 2005 to life-sustaining treatment. The case involved competing arguments from family members, clinical teams at Royal United Hospitals Bath NHS Foundation Trust, and the Court of Protection about withdrawal of clinically assisted nutrition and hydration. The ruling clarified principles previously considered in cases such as Airedale NHS Trust v Bland and Re F (Mental Patient: Sterilisation) and influenced subsequent practice in neurology, geriatric medicine, and bioethics.

Background

The dispute arose in the context of evolving jurisprudence on treatment withdrawal exemplified by Airedale NHS Trust v Bland and statutory frameworks from the Mental Capacity Act 2005, together with jurisprudential inputs from the Court of Protection, High Court of Justice, and the Family Division. Key professional bodies and institutions including the General Medical Council, the British Medical Association, Royal College of Physicians, and Royal College of Psychiatrists had issued guidance on disorders of consciousness, while academic commentary in outlets such as the British Medical Journal and the Lancet informed public debate. The case sat amid ongoing policy discussion by the Department of Health and engagement by advocacy groups like Compassion in Dying and NHS England.

Facts of the Case

The claimant, represented by family members and clinicians from a NHS Foundation Trust, had sustained catastrophic brain injury following a cardiorespiratory arrest and was diagnosed with a prolonged disorder of consciousness. Clinicians reported repeated assessments using protocols influenced by work at University College London and the Mayo Clinic and referenced neuroimaging studies originating from Johns Hopkins University and Massachusetts General Hospital research. The treating team proposed withdrawal of clinically assisted nutrition and hydration on the basis that continuation was not in the patient’s best interests, a position contested by members of the patient’s family who relied on religious and ethical perspectives articulated in submissions invoking precedents such as R (on the application of Nicklinson), R (on the application of Pretty), and decisions from the European Court of Human Rights.

Legal Issues

Central legal issues included the interpretation of “best interests” under the Mental Capacity Act 2005, the role of prior wishes and advance decisions under the Advance Decisions to Refuse Treatment Act 2005 regime, and the circumstances in which courts should authorise withdrawal of life-sustaining treatment. The court considered the relevance of clinical diagnosis categories established in literature from Harvard Medical School, the evidentiary status of functional neuroimaging studies from Oxford University and Cambridge University, and competing human rights claims grounded in the Human Rights Act 1998 and jurisprudence from the European Court of Human Rights, including Pretty v United Kingdom and cases concerning Article 2 and Article 8.

Judgment and Reasoning

A majority of the Supreme Court of the United Kingdom concluded that where clinicians and the Court of Protection agree that continued treatment is futile and not in the patient’s best interests, withdrawal of clinically assisted nutrition and hydration can be lawful. The judgment, authored with input from Lady Hale and Lord Neuberger, reiterated principles from Airedale NHS Trust v Bland and clarified the application of the Mental Capacity Act 2005 best interests test, emphasising consultation with family and reference to medical opinion shaped by practice from centres such as Royal Free Hospital and Kings College London. The court drew on comparative materials from Canadian and Australian jurisprudence, and considered ethical analyses published by scholars affiliated with Oxford Centre for Neuroethics and Harvard Kennedy School.

Significance and Impact

The decision provided authoritative guidance to NHS clinicians, the Court of Protection, and families on resolving disputes over continued life-sustaining treatment in prolonged disorders of consciousness. It influenced policy documents from NHS England, professional guidance by the General Medical Council and Royal College of Physicians, and informed academic commentary in the British Medical Journal, Health Affairs, and legal reviews from Oxford University Press. The ruling also affected litigation strategy in cases before the Court of Appeal and the High Court of Justice and shaped training curricula at institutions such as University College London and King's College London.

Subsequent Developments and Related Cases

Following the decision, courts handled subsequent disputes with reference to the principles in this ruling, including matters heard in the Court of Protection and appeals to the Court of Appeal that invoked the judgment alongside later decisions such as Re M (Medical Treatment). Academic and clinical research programs at University of Cambridge, Imperial College London, and King's College London expanded investigation into disorders of consciousness, while policy reviews by the Department of Health and Social Care and NHS England updated guidance. The case remains cited in subsequent judgments, bioethical literature from Georgetown University and Yale University, and multidisciplinary guidance involving neuroscience, ethics, and law.

Category:United Kingdom Supreme Court cases Category:Mental Capacity Act 2005